AiCuris: Dr. Alex Birkmann on Antiviral Drug Development for HSV
Alexander Birkmann, PhD, is a seasoned pharmaceutical professional with over 20 years of experience in antiviral drug development. He has held key positions at Bayer and AiCuris, contributing to the advancement of innovative anti-infective therapies. As Vice President of Virology and HSV Platform at AiCuris, he leads the scientific strategies for the NDA filing andContinue reading "AiCuris: Dr. Alex Birkmann on Antiviral Drug Development for HSV"
